Skip to content

Clinical Observation on Treatment of Vitiligo of Qi Stagnation and Blood Stasis Type with Guishao Qubai Decoction

Clinical Observation on Treatment of Vitiligo of Qi Stagnation and Blood Stasis Type with Guishao Qubai Decoction

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002119
Enrollment
Unknown
Registered
2025-11-04
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo

Interventions

Control Group:Fire filiform needles were applied to the lesioned areas once a week, with continuous treatment for 12 weeks.0.1% tacrolimus ointment was applied topically (0.03% tacrolimus ointment was
Treatment Group:Fire filiform needles were applied to the lesioned areas once a week, with continuous treatment for 12 weeks.0.1% tacrolimus ointment was applied topically (0.03% tacrolimus ointment w

Sponsors

Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1)Patients with non-segmental vitiligo of qi stagnation and blood stasis type who meet the above diagnostic criteria and TCM syndrome differentiation criteria; 2)Aged 18–75 years, regardless of gender; 3)With good compliance and who have signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1)Pregnant women and lactating women; 2)Patients with severe impairment of cardiac, hepatic, or renal function; 3)Patients with major diseases such as severe cardiovascular and cerebrovascular diseases, hematological diseases, severe hypertension, or severe diabetes mellitus; 4)Patients with scar constitution or allergic constitution; 5)Patients who have participated in other drug clinical trials within 1 month or are currently participating in other drug clinical trials.

Design outcomes

Primary

MeasureTime frame
Area of White Patches;

Secondary

MeasureTime frame
Vitiligo area scoring index,VASI;Presence of refractile dendritic melanocytes and cobblestone-like arranged refractile granules in the basal cell layer of different regions of target lesions (normal skin around white patches, perifollicular area of white patches, pigment islands of white patches) under skin CT;TCM Syndrome Score;VIPs-12 Scale Score;Peripheral Blood Immune and Oxidative Stress Indicato;

Countries

China

Contacts

Public ContactZhang Chenghui

Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine

470703367@qq.com13899958530

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026